lu-177-prostate-cancer - Sorry! Your Search Result Empty

The term 'theranostics' is an integration of the words 'therapeutics' and 'diagnostics'. Theranostic agents are paired agents, one an imaging agent th

Oligometastatic prostate cancer (OMPC) that has five or fewer sites of metastasis is considered a transitional state between localized and widespread

Before we go on to discuss the above topic at hand, let me explain PRRT. In PRRT, a radiopeptide is created by combining a small amount of radioactive

I am writing this blog to guide patients who would want to come to India for medical treatment. This is a step-by-step logistics guide and is entirely

I am a Prostate Cancer patient from USA (name withheld on request). I came to India, specifically to the Department of Nuclear Medicine & Molecular Im

Transarterial Chemoembolisation or TACE has been the initial treatment modality for HCC and has a huge body of evidence from several studies and clini

Yttrium-90 or Y90is a commonly used isotope in the medical field specially in departments like nuclear medicine and radiation oncology for radiation t

This overview provides the patient and the caregiver a peek at what to expect during a typical PRRT treatment with Lu177 (Lutathera) and it covers the

PRRT or Peptide Receptor Radionuclide Therapy is a type of Nuclear Medicine Therapy in which a cell-targeting protein or peptide is combined with a sm

Neuroendocrine tumours (NETs) are heterogeneous with varying behaviour. Treatment decisions are taken basis Histological studies plus imaging data and